A Day Up For InMed Pharmaceuticals Inc.
Tue, Sep 27, 2022 at 07:33 PM
InMed Pharmaceuticals Inc. (INM:NASDAQ) shot up at $6.71, a gain of 31.3%. On Tue, Sep 27, 2022, INM:NASDAQ touched a New 2-Week Intraday Low of $4.95. The stock appeared on our News Catalysts scanner on Fri, Sep 23, 2022 at 01:54 PM in the 'INVESTOR UPDATE' category. From Tue, Sep 13, 2022, the stock recorded 10.00% Up Days and 9.09% Green Days
The stock spiked on Mon, Sep 12, 2022 at $19.5 with a volume of 31M+.
About InMed Pharmaceuticals Inc. (INM:NASDAQ)
InMed Pharmaceuticals Inc is a Canada based pre-clinical stage biopharmaceutical company.
Top 10 Gainers:
- Avenue Therapeutics, Inc. (ATXI:NASDAQ), 106.25%
- Scienjoy Holding Corporation (SJ:NASDAQ), 47.9%
- Sonendo Inc. (SONX:NYSE), 42.74%
- X4 Pharmaceuticals, Inc. (XFOR:NASDAQ), 40.18%
- Antelope Enterprise Holdings Limited (AEHL:NASDAQ), 37.46%
- Grove Collaborative Holdings Inc. Class A (GROV:NYSE), 35.47%
- InMed Pharmaceuticals Inc. (INM:NASDAQ), 31.31%
- AN2 Therapeutics Inc. (ANTX:NASDAQ), 31.13%
- Intelligent Living Application Group Inc. (ILAG:NASDAQ), 28.43%
- Harrow Health, Inc. (HROW:NASDAQ), 27.86%